Bowen is at the forefront of developing Toll-like receptor (TLR) agonists, designed to stimulate immune responses for cancer and infectious diseases. Our pipeline focuses on two key approaches:

• Advanced Immunization Methods: Targeted immunization near lymph nodes.
• Intra-Tumor Injection: Developing vaccines for solid tumors such as skin, prostate, breast, thyroid, and cervical cancers.